Lynnette R Heath, the EVP & Chief HR Officer of $NVT, sold 24,360 shares of the company on 05-06-2026 for an estimated $4,081,181. We received data on the trade from a recent SEC filing. This was a sale of approximately 37.7% of their shares of this class of stock. Following this trade, they now own 40,200 shares of this class of $NVT stock.
$NVT Insider Trading Activity
$NVT insiders have traded $NVT stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $NVT stock by insiders over the last 6 months:
- LYNNETTE R HEATH (EVP & Chief HR Officer) has made 0 purchases and 2 sales selling 27,471 shares for an estimated $4,603,734.
- DER KOLK ROBERT J. VAN (President of EMEA and APAC) sold 21,500 shares for an estimated $2,513,178
- BETH WOZNIAK (Chair & CEO) has made 0 purchases and 3 sales selling 11,734 shares for an estimated $1,341,323.
- RANDOLPH A. WACKER (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 9,094 shares for an estimated $1,228,240.
- ARAVIND PADMANABHAN (EVP & Chief Technology Officer) sold 6,988 shares for an estimated $1,190,626
- JERRY W BURRIS sold 5,244 shares for an estimated $588,743
- GREG SCHEU sold 5,591 shares for an estimated $581,687
- SUSAN M. CAMERON sold 5,000 shares for an estimated $572,600
- DANITA K OSTLING sold 900 shares for an estimated $106,181
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$NVT Hedge Fund Activity
We have seen 392 institutional investors add shares of $NVT stock to their portfolio, and 326 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 3,847,016 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $392,280,221
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,983,680 shares (-76.6%) from their portfolio in Q4 2025, for an estimated $304,245,849
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,019,483 shares (+361.9%) to their portfolio in Q4 2025, for an estimated $205,926,681
- HOLOCENE ADVISORS, LP removed 1,533,505 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $156,371,504
- INTERVAL PARTNERS, LP removed 1,499,054 shares (-84.6%) from their portfolio in Q4 2025, for an estimated $152,858,536
- BANK OF AMERICA CORP /DE/ added 1,463,115 shares (+158.2%) to their portfolio in Q4 2025, for an estimated $149,193,836
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 1,408,763 shares (-78.8%) from their portfolio in Q4 2025, for an estimated $143,651,563
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$NVT Analyst Ratings
Wall Street analysts have issued reports on $NVT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/20/2025
To track analyst ratings and price targets for $NVT, check out Quiver Quantitative's $NVT forecast page.
$NVT Price Targets
Multiple analysts have issued price targets for $NVT recently. We have seen 10 analysts offer price targets for $NVT in the last 6 months, with a median target of $186.0.
Here are some recent targets:
- Vladimir Bystricky from Citigroup set a target price of $187.0 on 05/05/2026
- Jeffrey D. Hammond from Keybanc set a target price of $185.0 on 05/04/2026
- Deane Dray from RBC Capital set a target price of $180.0 on 05/04/2026
- Julian Mitchell from Barclays set a target price of $190.0 on 05/04/2026
- Joe Ritchie from Goldman Sachs set a target price of $187.0 on 05/04/2026
- Alexander Virgo from Evercore ISI Group set a target price of $190.0 on 05/04/2026
- Neal Burk from UBS set a target price of $200.0 on 05/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
